Tags

Type your tag names separated by a space and hit enter

Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Clin Infect Dis. 2002 Nov 01; 35(9):e92-5.CI

Abstract

Thirty-eight of 295 subjects participating in a randomized, double-blind, placebo-controlled trial of the efficacy of daily administration of atovaquone/proguanil for malaria prevention developed malaria at some time during the 20-week prophylaxis period. These subjects (3 atovaquone/proguanil recipients and 35 placebo recipients) were treated with 4 tablets of atovaquone/proguanil per day for 3 days. Atovaquone/proguanil provided safe, well-tolerated, and effective therapy for uncomplicated malaria in nonimmune Indonesians.

Authors+Show Affiliations

Parasitic Diseases Program, US Naval Medical Research Unit 2, Jakarta, Indonesia.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

12384852

Citation

Lacy, Mark D., et al. "Atovaquone/proguanil Therapy for Plasmodium Falciparum and Plasmodium Vivax Malaria in Indonesians Who Lack Clinical Immunity." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 35, no. 9, 2002, pp. e92-5.
Lacy MD, Maguire JD, Barcus MJ, et al. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. Clin Infect Dis. 2002;35(9):e92-5.
Lacy, M. D., Maguire, J. D., Barcus, M. J., Ling, J., Bangs, M. J., Gramzinski, R., Basri, H., Sismadi, P., Miller, G. B., Chulay, J. D., Fryauff, D. J., Hoffman, S. L., & Baird, J. K. (2002). Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 35(9), e92-5.
Lacy MD, et al. Atovaquone/proguanil Therapy for Plasmodium Falciparum and Plasmodium Vivax Malaria in Indonesians Who Lack Clinical Immunity. Clin Infect Dis. 2002 Nov 1;35(9):e92-5. PubMed PMID: 12384852.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. AU - Lacy,Mark D, AU - Maguire,Jason D, AU - Barcus,Mazie J, AU - Ling,Judith, AU - Bangs,Michael J, AU - Gramzinski,Robert, AU - Basri,Hasan, AU - Sismadi,Priyanto, AU - Miller,Gerri B, AU - Chulay,Jeffrey D, AU - Fryauff,David J, AU - Hoffman,Stephen L, AU - Baird,J Kevin, Y1 - 2002/10/09/ PY - 2002/04/01/received PY - 2002/10/18/pubmed PY - 2002/11/26/medline PY - 2002/10/18/entrez SP - e92 EP - 5 JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin Infect Dis VL - 35 IS - 9 N2 - Thirty-eight of 295 subjects participating in a randomized, double-blind, placebo-controlled trial of the efficacy of daily administration of atovaquone/proguanil for malaria prevention developed malaria at some time during the 20-week prophylaxis period. These subjects (3 atovaquone/proguanil recipients and 35 placebo recipients) were treated with 4 tablets of atovaquone/proguanil per day for 3 days. Atovaquone/proguanil provided safe, well-tolerated, and effective therapy for uncomplicated malaria in nonimmune Indonesians. SN - 1537-6591 UR - https://www.unboundmedicine.com/medline/citation/12384852/Atovaquone/proguanil_therapy_for_Plasmodium_falciparum_and_Plasmodium_vivax_malaria_in_Indonesians_who_lack_clinical_immunity_ L2 - https://academic.oup.com/cid/article-lookup/doi/10.1086/343750 DB - PRIME DP - Unbound Medicine ER -